The International Foundation for Gastrointestinal Disorders announced that the online nomination period has begun for the 2019 Research Recognition Awards. Since 2003, the awards have recognized and ...

When gastric acid secretion is increased, there is a greater risk of developing motility disorders, such as GERD, peptic ulcer disease (PUD), and gastritis. Management of these disorders can be a ...

The connection between disordered eating and GI seems like an easy one to make. Kyle Staller, MD, MPH, director of the gastrointestinal motility laboratory at Massachusetts General Hospital, said ...

Chronic Intestinal Pseudo-Obstruction (CIPO) and related gastrointestinal motility disorders constitute a group of rare but debilitating conditions that mimic mechanical obstruction despite the ...

The Neuro-Gastroenterology and Pediatric Motility Center is a nationally recognized institution, one of the few in the country that is dedicated to diagnosing and treating motility disorders and neuro ...

Takeda Pharmaceutical and Theravance Biopharma have entered into a global license, development and commercialization agreement. 1. The agreement centers on TD-8954, a selective 5-HT4 receptor agonist.

FGID occurs due to the abnormal functioning of the GI tract. A recent study indicated that around 40% of the world's population is affected by FGID. 2 In comparison to men, women are more commonly ...

Some of the most intractable gastrointestinal disorders, such as irritable bowel syndrome and inflammatory bowel disease, are motility disorders, where the contents of the intestines don’t proceed ...

CHICAGO, May 10, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a clinical-stage biopharmaceutical company, will present Phase 2 data of TZP-102, an orally-administered ghrelin agonist in ...